Velcheti; Vamsidhar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Velcheti; Vamsidhar.The latest application filed is for "timed alternate administration of decitabine and 5-azacytidine for cancer treatment".

Company Profile

12.15.17

Velcheti; Vamsidhar - Scarsdale NY
Velcheti; Vamsidhar - Pepper Pike OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Timed Alternate Administration Of Decitabine And 5-azacytidine For Cancer Treatment App 20220226355 - Saunthararajah; Yogen ; et al.	2022-07-21
Recurrence prognosis and prediction of added benefit of adjuvant chemotherapy in early stage non-small cell lung cancer with radiomic features on baseline computed tomography Grant 11,350,901 - Madabhushi , et al. June 7, 2	2022-06-07
Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC) Grant 11,055,844 - Madabhushi , et al. July 6, 2	2021-07-06
Predicting recurrence in early stage non-small cell lung cancer (NSCLC) using spatial arrangement of clusters of tumor infiltrating lymphocytes and cancer nuclei Grant 10,956,795 - Madabhushi , et al. March 23, 2	2021-03-23
Methods and apparatus for predicting benefit from immunotherapy using tumoral and peritumoral radiomic features Grant 10,950,351 - Madabhushi , et al. March 16, 2	2021-03-16
Predicting response to immunotherapy using computer extracted features relating to spatial arrangement of tumor infiltrating lymphocytes in non-small cell lung cancer Grant 10,902,256 - Madabhushi , et al. January 26, 2	2021-01-26
Predicting recurrence in early stage non-small cell lung cancer (NSCLC) with integrated radiomic and pathomic features Grant 10,846,367 - Madabhushi , et al. November 24, 2	2020-11-24
Distinguishing hyperprogression from other response patterns to PD1/PD-L1 inhibitors in non-small cell lung cancer with pre-therapy radiomic features Grant 10,839,513 - Vaidya , et al. November 17, 2	2020-11-17
Predicting immunotherapy response in non-small cell lung cancer with serial radiomics Grant 10,575,774 - Madabhushi , et al.	2020-03-03
Predicting immunotherapy response in non-small cell lung cancer patients with quantitative vessel tortuosity Grant 10,492,723 - Madabhushi , et al. De	2019-12-03
Distinguishing Hyperprogression From Other Response Patterns To Pd1/pd-l1 Inhibitors In Non-small Cell Lung Cancer With Pre-ther App 20190347789 - Vaidya; Pranjal ; et al.	2019-11-14
Predicting response to pemetrexed chemotherapy in non-small cell lung cancer (NSCLC) with baseline computed tomography (CT) shape and texture features Grant 10,458,895 - Madabhushi , et al. Oc	2019-10-29
Predicting immunotherapy response in non-small cell lung cancer with serial quantitative vessel tortuosity Grant 10,441,215 - Madabhushi , et al. Oc	2019-10-15
Predicting disease recurrence following trimodality therapy in non-small cell lung cancer using computed tomography derived radiomic features and clinico-pathologic features Grant 10,441,225 - Madabhushi , et al. Oc	2019-10-15
Predicting Response To Immunotherapy Using Computer Extracted Features Of Cancer Nuclei From Hematoxylin And Eosin (h&e) Stained App 20190259154 - Madabhushi; Anant ; et al.	2019-08-22
Predicting Recurrence And Overall Survival Using Radiomic Features Correlated With Pd-l1 Expression In Early Stage Non-small Cel App 20190259156 - Madabhushi; Anant ; et al.	2019-08-22
Predicting Disease Recurrence Following Trimodality Therapy In Non-small Cell Lung Cancer Using Computed Tomography Derived Radi App 20190254611 - Madabhushi; Anant ; et al.	2019-08-22
Predicting Response To Immunotherapy Using Computer Extracted Features Relating To Spatial Arrangement Of Tumor Infiltrating Lym App 20190258855 - Madabhushi; Anant ; et al.	2019-08-22
Computerized analysis of computed tomography (CT) imagery to quantify tumor infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) Grant 10,346,975 - Madabhushi , et al. July 9, 2	2019-07-09
Recurrence Prognosis And Prediction Of Added Benefit Of Adjuvant Chemotherapy In Early Stage Non-small Cell Lung Cancer With Rad App 20190159745 - Madabhushi; Anant ; et al.	2019-05-30
Methods And Apparatus For Predicting Benefit From Immunotherapy Using Tumoral And Peritumoral Radiomic Features App 20190156954 - Madabhushi; Anant ; et al.	2019-05-23
Predicting Recurrence In Early Stage Non-small Cell Lung Cancer (nsclc) Using Spatial Arrangement Of Clusters Of Tumor Infiltrating Lymphocytes And Cancer Nuclei App 20190087693 - Madabhushi; Anant ; et al.	2019-03-21
Predicting Recurrence In Early Stage Non-small Cell Lung Cancer (nsclc) With Integrated Radiomic And Pathomic Features App 20190087532 - Madabhushi; Anant ; et al.	2019-03-21
Prediction of recurrence of non-small cell lung cancer with tumor infiltrating lymphocyte (TIL) graphs Grant 10,078,895 - Madabhushi , et al. September 18, 2	2018-09-18
Predicting Immunotherapy Response In Non-small Cell Lung Cancer With Serial Quantitative Vessel Tortuosity App 20180242906 - Madabhushi; Anant ; et al.	2018-08-30
Predicting Immunotherapy Response In Non-small Cell Lung Cancer Patients With Quantitative Vessel Tortuosity App 20180242905 - Madabhushi; Anant ; et al.	2018-08-30
Predicting Immunotherapy Response In Non-small Cell Lung Cancer With Serial Radiomics App 20180247410 - Madabhushi; Anant ; et al.	2018-08-30
Prediction of recurrence of non-small cell lung cancer Grant 10,049,770 - Madabhushi , et al. August 14, 2	2018-08-14
Predicting Response To Pemetrexed Chemotherapy In Non-small Cell Lung Cancer (nsclc) With Baseline Computed Tomography (ct) Shape And Texture Features App 20170351939 - Madabhushi; Anant ; et al.	2017-12-07
Computerized Analysis Of Computed Tomography (ct) Imagery To Quantify Tumor Infiltrating Lymphocytes (tils) In Non-small Cell Lung Cancer (nsclc) App 20170352157 - Madabhushi; Anant ; et al.	2017-12-07
Prediction Of Recurrence Of Non-small Cell Lung Cancer App 20170193175 - Madabhushi; Anant ; et al.	2017-07-06
Prediction Of Recurrence Of Non-small Cell Lung Cancer With Tumor Infiltrating Lymphocyte (til) Graphs App 20170193657 - Madabhushi; Anant ; et al.	2017-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.